//
blend
Semaglutide + Cagrilintide Blend
GLP-1 / amylin dual-pathway combination for metabolic research
Sign in to view pricing
Dosage:10mg (5mg Semaglutide + 5mg Cagrilintide)
Storage:Store in refrigerator at 4°C, tightly sealed, away from heat, light and moisture.
Availability:Coming Soon
This product is coming soon. Join the waitlist to be notified when it's available.
⚠️
For Research Use Only
These products are intended for laboratory research use only and are not for human consumption. Not for use in food, drug, household, or cosmetic applications. All research should be conducted in accordance with applicable safety guidelines and regulations.
Description
This advanced blend combines semaglutide (a GLP-1 receptor agonist) with cagrilintide (an amylin/calcitonin receptor agonist) for research into dual-pathway incretin and amylin co-agonism. The CagriSema clinical program has generated significant interest in how combined GLP-1 and amylin receptor engagement may produce differentiated metabolic outcomes.
Research Summary
The CagriSema clinical program and related research have explored how simultaneous GLP-1 and amylin receptor engagement compares to monotherapy, with studies examining complementary satiety signaling and metabolic endpoint effects.
Storage & Handling
❄️
Storage Temperature
Store in refrigerator at 4°C, tightly sealed, away from heat, light and moisture.. Keep frozen until ready to reconstitute.
💧
Reconstitution
Use sterile water for injection. Allow to reach room temperature before reconstitution.
